menu
    • menu

    Company profile for Seaport Therapeutics

    NEW Drugs in Dev: 4
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Seaport Therapeutics is a clinical-stage biopharmaceutical entity at the forefront of advancing novel neuropsychiatric medications to address significant unmet patient needs. Our approach involves leveraging our proprietary Glyph technology platform to overcome limitations previously hindering the progress of clinically validated mechanisms. Spearheaded by a seasoned team with a track record of involvement in inventing and dev...
    Seaport Therapeutics is a clinical-stage biopharmaceutical entity at the forefront of advancing novel neuropsychiatric medications to address significant unmet patient needs. Our approach involves leveraging our proprietary Glyph technology platform to overcome limitations previously hindering the progress of clinically validated mechanisms. Spearheaded by a seasoned team with a track record of involvement in inventing and developing KarXT and other neuropsychiatric medicines, we are guided by an extensive network comprising renowned scientists, clinicians, and key opinion leaders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Seaport TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Seaport Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://seaporttx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/seaport-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Seaport Therapeutics Presents at 44th Annual JP Morgan Conference
    Seaport Therapeutics Presents at 44th Annual JP Morgan Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105003930/en/Seaport-Therapeutics-to-Present-at-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Seaport Therapeutics Validates Glyph for Oral Bioavailability
    Seaport Therapeutics Validates Glyph for Oral Bioavailability

    08 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251208286517/en/Seaport-Therapeutics-Presents-Data-Further-Validating-Glyph-Platforms-Ability-to-Enhance-Oral-Bioavailability-and-Expand-Therapeutic-Reach

    BUSINESSWIRE
    08 Dec 2025
    Share Share
    Seaport Therapeutics To Present At 2025 RBC Healthcare Conf
    Seaport Therapeutics To Present At 2025 RBC Healthcare Conf

    04 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251204684749/en/Seaport-Therapeutics-to-Present-at-2025-RBC-Capital-Markets-Healthcare-Private-Company-Conference

    BUSINESSWIRE
    04 Dec 2025
    Share Share
    Seaport Therapeutics To Present At Stifel Healthcare Conference
    Seaport Therapeutics To Present At Stifel Healthcare Conference

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104410929/en/Seaport-Therapeutics-to-Present-at-Stifel-2025-Healthcare-Conference

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Seaport Therapeutics to Join Upcoming Investor Conferences
    Seaport Therapeutics to Join Upcoming Investor Conferences

    18 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250918714981/en/Seaport-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    18 Sep 2025
    Share Share
    Seaport Advances Second Candidate into Ph 1 with GlyphAgo Dosing
    Seaport Advances Second Candidate into Ph 1 with GlyphAgo Dosing

    11 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250911263639/en/PureTech-Founded-Entity-Seaport-Therapeutics-Advances-Second-Therapeutic-Candidate-into-Clinical-Development-with-Dosing-of-First-Participant-in-Phase-1-Study-of-GlyphAgo-SPT-320-in-Healthy-Volunteers

    BUSINESSWIRE
    11 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search